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Summary.-Male and female Wistar rats were administered sodium saccharin for
life (2 yr) either in the drinking water or diet. The maximum palatable dose of
saccharin in the drinking water was found to be 2 g/kg/day and, even then, there was
some voluntary restriction of fluid intake in the males. By contrast, double this dose
-namely 4 g/kg/day, was palatable in the diet. A control group of rats of both sexes
received saccharin-free diet and drinking water. Mild urothelial hyperplasias
developed from 85 weeks in rats of both sexes receiving saccharin either in the
drinking water or diet; the incidence was statistically significant in both the bladders
and kidneys ofrats receiving the higher dose ofsaccharin in the diet, but in the kidneys
only ofrats receiving the lower dose ofsaccharin in the drinking water. Telangiectasia
of the vasa recta was significant in saccharin-treated rats of both sexes at both doses.
A very low incidence of bladder tumours, exclusively in males receiving the higher
saccharin dose in the diet was seen from95 weeks. No consistent relationship between
bladder epithelial hyperplasias and crystalluria could be demonstrated, although all
3 bladder tumours were associated with some form of mineralisation. Results
suggest a particular susceptibility of males to saccharin treatment. The possibility
that saccharin may promote, or enhance, the development of latent tumour cells
already present in the experimental population, rather than initiate carcinogenesis
per se is considered.
SACCHARIN came under suspicion as a
possible bladder carcinogen after the
withdrawal of cyclamate from the GRAS
(generally regarded as safe) list in 1969
(Egeberg et al., 1970), following pre-
liminary reports that a dose-related inci-
dence of urinary-bladder tumours de-
veloped in rats fed high doses of a 10:1
cyclamate: saccharin mixture (Price et al.,
1970). Although cyclamate was suspected
at the time, either saccharin or the com-
bination of both sweeteners could equally
well have been responsible for the tumori-
genesis. New evidence, subsequently pre-
sented by Bryan et al. (1970) confirmed
earlier observations that implantation of
saccharin-containing cholesterol pellets
into the urinary bladders ofmice increased
the bladder-tumour incidence over that
induced by implantation of cholesterol
pellets alone (Allen et al., 1957). These
results conflicted with single-generation
feeding studies that had failed to demon-
strate a significant carcinogenic effect of
saccharin, in the urinary bladder or in any
other organ (Fitzhugh. et al., 1951; Taylor
et al., 1968; Roe et al., 1970; Lessel, 1971).
To attempt to assess what role, if any,
saccharin might play in urothelial car-
cinogenesis, we have investigated the
effects of chronic administration to rats of
high doses of saccharin, given either in
drinking water or in the diet to simulate
the normal routes of human exposure.
Some of the preliminary, numerical data
from these experiments have been pub-
lished (Hicks & Chowaniec, 1977; Hicks
et al., 1978). In common with concurrent
trials in different laboratories (Taylor &
Friedman, 1974; Tisdel et al., 1974;
Arnold et al., 1979) we observed a low
incidence of bladder tumours in sacchar-J. CHOWANIEC AND R. M. HICKS
in-fed male animals. The bladder patho-
logy is discussed in relation to the degree
of urolithiasis observed, which -differed
according to the method of saccharin
administration. This paper describes histo-
pathologicalchangesinthe urinary bladder
throughout the animals' life-span and
also some incidental pathological effects
observed in other organs. Our re-
sults are related to those of recent
saccharin studies in other laboratories, and
the possible mechanisms of action of
saccharin on the urothelium are discussed.
MATERIALS AND METHODS
The sodium saccharin (supplied by Fisons,
Loughborough, Leicestershire; manufactured
by Boots Co., Nottingham, England) was a
fine, white crystalline powder, soluble in
water. Gas-liquid chromatographic analysis
(by courtesy of Dr B. Stavric, Bureau of
Chemical Safety, Health Protection Branch,
Health and Welfare Canada, Ottawa) showed
it to contain small amounts ofseveral organic
solvent-soluble impurities, notably 5 isomers
of ditolylsulphone. Quantitative analysis
demonstrated the major impurity to be
orthotoluenesulphonamide (OTS), for which
repeated measurements gave an average level
of 698 parts/106 (B. Stavric, personal com-
munication). A similar result was obtained by
the Battelle Institute from a single sample of
this saccharin (Hicks et al., 1973).
Animals and diet.-Specific-pathogen-free
Wistar rats, about 8 weeks old at the start of
the experiment, were maintained on pencilled,
Standard 41B Laboratory Rat Diet (E. Dixon
and Co., Ware, Herts, England) the com-
position and pesticide-residue levels of which
have been outlined by Clarke et al. (1977).
The standard vitamin mix contained 8000 i.u.
vitamin A/kg ofdiet and the mineral mix con-
tained, in addition to NaCl, 44 50 parts/106
Fe, 2-54 parts/106 Cu, 2-00 parts/106 I, 74 00
parts/106 Mn, 0-64 parts/106 Co and 91-50
parts/106 Mg. No detectable levels ofaflatoxin
were present. Tap water was provided for all
animals. Saccharin was incorporated either
into the diet or drinking water for some groups
of animals as indicated below. Diet and
drinking water were available ad libitum. The
experiment was terminated at 2 years.
Experimental groups.-The rats were
divided randomly into 3 experimental groups,
2 of which were administered sodium
saccharin orally.
Group A. Saccharin in drinking water: 75
male and 50 female rats were given the
sodium saccharin in the drinking water. The
concentration ofthis solution was periodically
adjusted so that the average dose received
was 2 g saccharin/kg/day (equivalent to about
4% of the diet). Higher doses were unpalat-
able and the animals would not drink
sufficient to remain healthy.
Group B. Saccharin in the diet: 75 males
and 75 females received the sodium saccharin
incorporated intopencilled, 41B diet (courtesy
of E. Dixon and Co., Ware, Herts, England)
to give an average dose of 4 g/kg/day (7-8%
of the diet), which was well tolerated.
Group C. Controls: 55 male and 50 female
rats remained untreated.
Animal maintenance.-The rats were
housed in groups of 5 in air-filtered rooms at
19-22°C with a relative humidity of 55-60%.
Their weights, food and water intakes were
measured at regular intervals. Changes in the
quality of fur, eyes, general physical appear-
ance or behaviour and the development of
haematuria or palpable masses were re-
corded. Sick or infected animals were imme-
diately isolated. Urinary pH was measured
periodically and, because an increased urine
alkalinity and urolithiasis was observed in
some Group A males by 27 weeks, all males in
this group were then given sodium saccharin
in a 1% solution of ammonium chloride to
restore urine acidity (Levi et al., 1971; Flaks
& Clayson, 1975). This saccharin/ammonium
chloride mixture was obviously distasteful
and, after 4 weeks, the ammonium chloride
concentration was therefore reduced to 0-5%
and maintained at this level for all Group A
males for the duration of the experiment.
Twenty-five of the control males (Group C)
were given ammonium chloride at the same
concentrations. No differences in weight, food
or fluid consumption were observed between
these animals and the untreated male con-
trols. No similar urinary pH problems were
encountered in females receiving saccharin in
the drinking water or in animals of either sex
receiving the higher dose of saccharin in the
diet.
Sampling ofanimalsforpathological changes.
-To assess any treatment-related morpho-
logical alterations of the bladder epithelium,
rats from all groups were periodically sacri-
ficed. Animals were chosen at random unless
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any individuals presented with haematuria, or
were found moribund, in which case these
were preferentially selected (Table I).
Throughout both the first and second years
all animals found dead were autopsied and,
where possible, their major organs processed
for histology. Survivors were killed by cervical
dislocation between weeks 94 and 105. The
urethra was clamped and the bladder trans-
murally inflated with 0 5-1 0 ml of 0dIM
cacodylate-buffered 400 formaldehyde (pH
7 4) for 5 min. The bladder was then excised,
bisected longitudinally and transilluminated
with a dissecting microscope. This procedure
allowed calculi or tumours as small as 10 mm
diam. to be detected, and the bladders were
also carefully inspected for the presence of
parasites. Representative areas from appar-
ently normal and abnormal bladders were
processed for electron microscopy (report in
preparation) and the remainder of each
bladder was fixed in the cacodylate-buffered
formaldehyde. All major organs were sur-
veyed macroscopically. Both kidneys and
samples of lung, liver, spleen, pancreas,
ovaries and uterus were similarly fixed for
histopathological assessment. Any other
organ showing an abnormality was also taken.
Sections of the paraffin-embedded tissues
wN,ere stained wNith Cole's haematoxylin and
eosin.
Histopathological assessment of tumours and
statistical analysis.-The WHO classification
outlined by Pugh (1973) wasused to gradeand
stage the bladder tumours. Patterns of
bladder tumour growth were also assessed
according to Tiltman & Friedell (1971). Inci-
dental pathology was diagnosed using WHO/
[ARC criteria for the rat (1973; 1976).
Throughout, the data were statistically
analysed using the Chi-square test for 2 x 2
contingency tables with a correction for small
numbers according to Yates (1934). However,
where the smallest expected value was less
than 5, this test was inappropriate and the
Fisher Exact Probability Test (Siegel, 1956)
was employed instead, where indicated in the
Results. For statistical analysis of the inci-
dence of urothelial lesions, the "effective
number" of rats, defined as the number of
rats from each experimental group considered
to have lived long enough for a particular
urothelial lesion to develop, was used. The
length of time necessary for development, or
'effective time", was the period which
elapsed before observation of the first lesion
in that group. Hence, if the first urothelial
lesion, e.g. hyperplasia, was observed at X
weeks, the number of rats alive at X weeks
was considered the "'effective number" and
X weeks the "effective time". This eliminated
from the calculations those animals which had
died or were sacrificed before the latent
period of hyperplasia formation had elapsed,
leaving only the true number at risk.
RESULTS
Urine pH and the development of
crystalluria
Throughout the 2 yr experiment the
urine pH value of untreated control rats
(Group C), both male and female, averaged
between 6-0 and 6-5. Similar values were
recorded for both Group B (4 g saccharin/
kg/day in the diet) males and females and
Group A (2 g saccharin/kg/day in water)
females. In Group A males, however, by
27 weeks the average urinary pH had risen
to above 7 0 and some individuals within
this group had pH values of 8-5 or 9 0. In
3 of these animals, the rise in pH was
accompanied by marked crystalluria,
sufficient to cause urethral blockage and
subsequent death. To prevent further
mortality, the pH changes in Group A
males were corrected by addition of
ammonium chloride to the saccharin in
the drinking water, thus returning their
urinary pH to 6-0 or 6-5. No gross
crystalluria was subsequently found but
the ammonium chloride did not prevent
development of microcalculi in their kid-
neys, the percentage incidence of which
was similar to that in Group A females not
receiving ammonium chloride (see Kidney
Pathology).
In the bladders of 3 saccharin-fed males
from Group B, mineralized deposits or
free-lying calculi were present; the 2
largest calculi measured 2 mm in diameter.
The mineralized deposits were detected
microscopically and consisted of crystal-
line material adherent to, or within the
urothelium or mucoproteinaceous secre-
tions.
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FIG. 1. Weight gain ofrats in the 3 treatment
groups from Week 0 to Week 80 of the
experiment. A. Males. B. Females.
* * untreated controls.
* * 2 g saccharin/kg/day (in water).
* * 4 g saccharin/kg/day (in diet).
Growth
(1) Group A animals (saccharin 2 g/kg/
day, in drinking water). This intake of
saccharin was associated with a slower
weight gain and a final body weight lower
than controls for both sexes (Fig. 1).
Liquid intake decreased early in the
experiment, especially in males. After
addition of ammonium chloride to their
drinking water, there was an increased
fluid consumption and their liquid intake
returned to 90%0 of control values. In
females also, liquid consumption remained
slightly below that of controls. Food con-
sumption in saccharin-treated males was
reduced by 10% of control values but in
females, remained comparable to that of
controls.
(2) Group B animals (saccharin 4 g/kg/
day, in the diet). The weight gain for
males in Group B was greater than for
those of Group A, but final body weights
were still lower than controls for both
sexes (Fig. 1). The depression in growth
was not, however, accompanied by re-
duced food or water intakes for either sex.
Indeed, during the second year, fluid con-
sumption rose by an average of 1000% in
males and 35%0 in females above control
values, Stool-softening or mild diarrhoea
also occurred.
Survival
The numbers of rats alive at, and those
which died or were sacrificed between,
defined times in all experimental groups
are presented in Table I. By 85 weeks
mortality was generally higher among all
females than males, but the difference was
not statistically significant in any group.
Despite the initial rise in mortality due to
urolithiasis in Group A males, the overall
mortality rate in this group did not sig-
nificantly differ from controls. A marginal
increase in death rate was apparent to-
wards the end of the experiment in Croup
B males. However, at the 5% signifi-
cance level, there was no difference in
survival or extent of exposure to risk of
death (Peto et al., 1977) between any
treated and/or untreated group for either
sex at any time considered, regardless of
whether the randomly sacrificed animals
were included or excluded from the calcu-
lations, as estimated from Table I.
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TABLE I.-Thefate and survival of rats in all treatment groups
A. 2g sacch/kg/day
C. Controls in water
Weeks of A
treatment Sex L S D L S D
0 M 55 - 75
F 50 50 -
15 M 54 1 73 2*
F 50 50
25 M 54 70 3
F 50 49 1
40 M 53 1+ 67 1* 2
F 46 1 3 48 1
55 M 51 2 65 1 1
F 45 1 46 2
70 M 49 1 1 65 -
F 43 1 1 44 2 -
85 M 47 2 64 1
F 35 1 7 37 2* 5
100 M 37 2 8 49 5++++ 10
F 13 19.... 3 29 4++++ 4
105 M 36 1 48 1
F 13 - 26 3
B. 4g sacch/kg/day
in diet
L S D
75 -
75
72 3
72 3
69 3
69 3 -
66 3 -
66 3
61 4 1
59 6+++ 1
55 2+ 4
52 2 5
49 3++ 3**
41 2+ 9
12 27+++ 10
16 13 12
- 12
16
L=number of animals alive.
S=number of animals sacrificed since the last time indicated.
D=number of animals found dead since the last time indicated.
* each asterisk represents one animal with haematuria.
+ each cross represents one animal killed because moribund.
TABLE II.-Histopathological lesions in selected organs of rats in all
experimental groups
No. ratsusable:
Lungs
haemorrhage
leucocyte infiltration
oedema
fibrosis
squamous metaplasia
Liver
fatty change
zonal necrosis
focal leucocyte infiltration
bile-duct proliferation and/or dilation
non-specific hepatitis
Reticuloendothelial/haematopoietic system
extramedullary haematopoeisis spleen
non-specific reactive spleen/lymph nodes
spleen telangiectasia
lymphosarcoma/leukaemia
Mammary
fibroadenoma
adenocarcinoma
papillary carcinoma
Males
Dose g/kg/day
0(C) 2(A) 4(B)
52 71 70
8
10
3
1
6 6
9 11
2 3
3 2
5 8
1 2 4
- 6 5
1 4
1 2
1
1
4 2
Females
Dose g/kg/day
0(C) 2(A) 4(B)
46 44 68
8 6 4
10 10 15
2 2 9
2 3 3
1
7 6 4
1 5 4
2
1 4 -
1
_ -_ 7
- 1 1
1 1
2
3
1
6 3
1360
No. rat8 u8able:
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TABLE II.-contd.
Males
Dose g/kg/day
0(C) 2(A) 4(B)
52 71 70
Females
Dose g/kg/day
0(C) 2(A) 4(B)
46 44 68
Uterus
endometritis
cystic/adenomatous endometrial hyperplasia
vascular/fibrous polyp
adenocarcinoma
cervical stenosis
Ovary
serous cyst
2 3 --
2 2 1
3 1 2
2 - 1
1
4
Pancreas
atrophy
early islet-cell tumour
a Testis
atrophy
Leydig-cell tumour
aSkin
epidermoid cyst
squamous-cell papilloma
clear-cell carcinoma
aSubcutaneous tissue
fibroma
fibrosarcoma
2
1
2
1
- 1 1
1
1 1
1 -
- 1 1
1 1
1
a Pharynx
squamous carcinoma
Tumours of uncertain origin
undifferentiated
poorly differentiated adenocarcinoma
Bladder
subepithelial lymphocytic foci
urothelial hyperplasia
urothelial tumourb
a Ureter
urothelial tumourb
Kidney
hyaline casts in tubules
inflammatory cell infiltrates
fatty degeneration
telangiectasia of vasa recta
hyperplasia of renal pelvic urothelium
urothelial tumour of renal pelvisb
liposarcoma
hypernephroma
pelvic/subepithelial calcification
microcalculi
1
1 - 2
2 9 6
3
1 -
25*** 21 19
9 17 8
1
- 7** 6*
1 10 10
1
4 1 5
2 30tt 16t
1 -
2
5 4
17*** 13 6
3 2 2
1 7** 6*
2 9 12
_ 1
1 _
4 3 5
13 19 18
* P<0-05
** P<0-01 For males and females combined per experimental group (d.f. = 1)
*** P<0-001
t P<0°01 For males only (d.f.=1) tt P<0.001j
a Organs were examined histologically only if abnormalities were detected macroscopically.
b See text for descriptive pathologySACCHARIN AND UROTHELIAL PATHOLOGY IN RATS
Pathology
The incidence of pathological lesions in
the urinary tract and other major organs
is shown in Table II.
(a) Bladder/ureter. Mucoproteinaceous
"plugs" were present in -30' ofbladders
from both treated and untreated male
rats; these could have been formed from
seminal ejaculate, since electron micro-
scopy occasionally revealed the presence
of spermatozoa within their matrices. No
bladder infestation with T. crassicauda or
any other parasite was detected, macro-
scopically or microscopically.
Histogenesis and pathology of urothelial
lesions
During the course ofthe experiment, the
transitional epithelium lining the urinary
bladder in all control females remained of
normal thickness (i.e. 3 cell layers)
although the basal-cell cytoplasm was
occasionally rarefied in old animals (Fig.
2). In 2 control males, focal urothelial
hyperplasia was seen by 101 weeks (Fig. 3,
Table II). Even in these animals, however,
the entire urothelium remained well
differentiated and there were very few
mitoses.
FiG. 2. Normal urothelium of a female control at 96 weeks, with complete differentiation into basal,
intermediate and superficial cells. The basal-cell cytoplasm shows patchy rarefaction. Toluidine
blue. x600.
a rG. 3. ocal urothellal hyperplasia in a control male rat at 101 weeks. Although the basal and
intermediate cell layers are increased in number, large, differentiated superficial cells persist.
Toluidine blue. x 530.
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In animals receiving the lower dose of
saccharin in the drinking water (Group A,
Table II) urothelial changes were more
frequent. In some females of this group,
moderate urothelial hyperplasia, up to 6
cells thick, developed from 100 weeks
although a few (not tabulated) had foci
4 cells thick earlier in the experiment.
Urolithiasis was not associated with
hyperplasia in any of these rats. In one
female, the apparently normal bladder
urothelium had an unusual number of
transitional cells in mitosis (Fig. 5), which
could not be attributed to worm infesta-
tion or calculi, since neither was present.
In Group A males, the 3 animals which
developed crystalluria or tiny bladder
calculi during the first 26 weeks had a
damaged urothelium and diffuse hyper-
plasia of up to 8 cell layers, probably
FIG. 4.-Part of the bladder of a male Group A rat with crystalluria at 21 weeks. Blood capillaries
(arrows) project into the damaged, hyperplastic urothelium and nodular downgrowths or micro-
papillae are formed. Haematoxylin and eosin. x 275.
FiG. 5.-Part ofthe bladder ofa female Group A rat at 89 weeks. The urothelium is fully differentiated
but mitotic activity (arrows) is prominent. Toluidine blue. x 400.
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FiG. 6.-The uretero-vesical junction of a male Group A rat at 102 weeks. A transitional-cell tumour,
composed ofpapillary outgrowths (p) and nodular downgrowths (n) is present. Haematoxylin and
eosin. x 125.
FiG. 7. Focal urothelial hyperplasia in the bladder of a male Group B rat at 95 weeks. A blood
capillary penetrates the intermediate and basal cell layers, where nuclear pleomorphism is occasion-
ally evident. Toluidine blue. x 560.
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attributable to local mechanical irritation.
In these bladders, the underlying capil-
laries sometimes projected into hyper-
plastic areas or micropapillae developed
(Fig. 4). After addition of ammonium
chloride to the saccharin solution, focal
hyperplasia, up to 6 cell layers, developed
in some males after 85 weeks, despite the
absence of crystalluria. At 102 weeks, one
transitional-cell tumour of the ureter was
observed in a Group A male at the
ureterovesical junction in the presence of
a calculus (Fig. 6). It consisted of areas of
gross, reactive hyperplasia into which the
underlying capillaries projected, forming
papillary outgrowths and circumscribed,
nodular epithelial downgrowths extending
to the proximate muscle layers. The
epithelium was well differentiated (Grade
1) and there were few mitoses, less than
one per high-power field (using a x 25
objective).
Histopathological changes in the uro-
thelium of female rats of Group B were
similar to those described for Group A
females but occurred somewhat earlier,
from 85 weeks onwards. Little alteration
ofthe transitional epithelium ofsaccharin-
fed males occurred until after 95 weeks,
when a few focal hyperplasias and 3
tumours were seen (Table II). In the
hyperplastic areas some intermediate and
basal cells were disorientated or pleo-
morphic, but the superficial cells re-
mained fully differentiated and mitoses
were rare. Capillaries occasionally pene-
trated the focally hyperplastic urothelium
of these saccharin-fed males as far as the
intermediate cell layers (Fig. 7) but this
was not seen in the focal hyperplasias in
control male bladders. The incidence of
urothelial hyperplasias in the "effective
number" of Group B rats of both sexes
(i.e. those rats alive and at risk at 85
weeks) was statistically significant
(P<0 05, Table III). Similar calculations
for Group A rats alive at 85 weeks
showed the incidence ofhyperplasias to be
not significant, if those associated with
iatrogenic urolithiasis by week 27 were
excluded (Table III).
Of the 3 bladder tumours detected in
Group B, the simplest was found at 102
weeks: the bladder contained a small,
spikey calculus, 2 mm in diameter, and
the urothelium showed areas of focal,
reactive, polyploid hyperplasia with Von
Brunn's nests (Fig. 8a). Elsewhere, a few
small papillomas were present, each con-
sisting of a central capillary covered by
well-differentiated, hyperplastic uro-
thelium in which the cells displayed slight
loss of polarity and pleomorphism (Fig.
8b). There was no epithelial invasion ofthe
fibrovascular papillary core and the
mitotic activity was up to 2 mitoses per
high-power field. This tumour was there-
fore diagnosed as a papillary carcinoma in
situ, Stage P.1.S., and Grade 1. The
second bladder tumour, also found at 102
TABLE III.-Theincidence ofurotheliallesion8 inthe effective number ofrat8from 85 week8a
Group
C Nil
A 2g
d
B 4g
di
Hyperplasias Tumours
Effective rc-- m
Treatment Sex numberb Bladder Kidney Bladder Kidney Ureter Total
M 47 82 2 2 1 3 0 0 0 0/82 F 35f Of 2 0 0
Saccharin/kg/ M 64 101 6 10** 10 19**** 0 0 1 1
ay (in water) F 37f 4j 9f 0 1 0
5
Saccharin/kg/ M 49\90 6 II1*** 10 22***** 3 ° 0 0 /11
ay (in diet) F 41 5 12 0 0 0
a When the first hyperplasias in the absence ofcrystalluria and also the first urothelial tumour (renalpelvis)
were seen.
b Number of rats alive at 85 weeks (from Table I) and therefore at risk of developing urothelial hyper- plasias or tumours.
* P<0-2 Fischer exact probability test.
** P<O.1
*** P<005 d
**** P<0.01 d.f. 1
***** P<0001 J
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(a)
(b)
FIG. 8. (a) Part of the bladder of a male Giroup B rat at 102 weeks in whlich a Z mm calculus
formed. The epithelium is thrown into hyperplastic, polypoid outgrowths penetrated by blood
capillaries; downgrowths, or Vonn Brunn's nests, of disorientated cells are also formed. Haema-
toxylin and eosin. x 160. (b) Another area from the same bladder. Here, simple papillomas, each
composed of a slender, fibrovascular core covered by well-differentiated urothelium, project into
the vesical lumen. Haematoxylin and eosin. x 135.
weeks, showed papillary outgrowths from
which circumscribed, nodular epithelial
downgrowths invaded the submucosa.
Irregularities in the basement membrane
were occasionally present and suggested
the escape of a few tumour cells (Fig. 9).
In some areas, normally differentiated
superficial cells at the urinary face could
still be discerned and in others, sandy,
mineralized deposits in the bladder lumen
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FIG. 9. Transitional-cell tumour in the bladder of a male Group B rat at 102 weeks. The epithelium
forms a raised, nodular mass ofpolypoid outgrowths and solid, circumscribed downgrowths extend-
ing into the submucosa. Mitotic figures are present (arrows) and, at points (arrowheads) tumour
cells appear to breach the basement membrane. Haematoxylin and eosin. x 180. (Reproduced by
courtesy of Int. Rev. Exp. Pathol., 1978, Academic Press.)
were in close contact with the tumour
surface. The tumour was staged at P.l.a.,
with a papillary-plus-infiltrating growth
pattern, a mitotic activity of up to 2
mitoses per high-power field and slight
cellular pleomorphism (i.e. Grade 1). The
third, and most advanced, bladder tumour
(found at 95 weeks) was multifocal and
included a pedunculated, papillary uro-
thelial outgrowth and adjacent nodular
areas of epithelial downgrowths into the
lamina propria (Fig. lOa). The stromal core
of the exophytic growth was invaded by
epithelial nests (Fig. lOb) and the neo-
plastic areas were staged at P.L.a.
Throughout, the tumour epithelium was
composed of closely-packed, disorientated
cells with darkly-staining, pleomorphic
nuclei. Mitotic activity was prominent,
with up to 3 mitoses per high-power field,
Grade 2. In a few areas, sandy mineral-
ization was present in the bladder
lumen, close to the surface of the
tumour.
(b) Kidney. In the renal medulla,
pyramid, papilla and fornix, calculi and/or
mineralization were microscopically visible
in all 3 groups, and were more frequent in
untreated females than in untreated males
(Table II). During the second year of the
experiment, numerous microcalculi (small,
crystalline deposits within or around the
collecting tubules of the renal papilla)
developed in saccharin-treated male and
female rats of all groups, but more
frequently in Group A, irrespective of
ammonium chloride treatment. It is note-
worthy that saccharin treatment caused a
significant increase in renal microcalculi in
males (Group A, P<0001; Group B,
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FIG. 1O.-(a) Part of a multifocal transitional-cell tumour in the bladder of a male Group B rat at 95
weeks. A pedunculated urothelial papilloma projects into the bladder lumen. Adjacent nodular
urothelial downgrowths (arrows) extend into the oedematous mesenchyme. Sandy, mineralised
deposits on the tumour surface have caused section scoring. Haematoxylin and eosin. x 45.
(b) Enlargement ofthe papillary stem shown above. Nests ofpleomorphic, disorientated transitional
cells have invaded the fibrovascular core and adjacent bladder wall. Haematoxylin and eosin. x 125.
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FIGe. 11.-Renal fornix of a control male rat at 102 weeks. Mineralised foci have formed beneath and
within the mildly hyperplastic urothelium that is focally eroded at the luminal surface (arrow).
Some concretions and associated debris lie free in the renal pelvic lumen. Haematoxylin and
eosin. x 110.
Fia. 12.-Longitudinal section through the kidney of a female Group A rat at 89 weeks. Branches of
the vasa recta are dilated and congested with thrombi, some of which are beginning to calcify
(arrows). Haematoxylin and eosin. x 16.
FiG. 13. The renal fornix of a male Group A rat at 100 weeks, showing hyperplasia of the renal
papilla and associated vascular telangiectasis. Haematoxylin and eosin. x 65.
FIG. 14. Transitional cell tumour of the renal pelvis in a female Group A rat at 85 weeks. The
neoplastic urothelium, composed of disorientated, pleomorphic cells and areas of squamous change,
is penetrated by blood capillaries, and an early papillary process is featured. Haematoxylin and
eosin. x 150.
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P<001) but not in females. Furthermore,
the percentage incidence of microcalculi
was higher in all Group A animals than in
Group B, although the former received less
saccharin,but indrinking water.In animals
of all groups, sub- or intra-epithelial min-
eralized deposits were occasionally foundin
the renal pelvis, particularly at the fornix.
In places, calculi were extruded into the
pelvic lumen together with necrotic
epithelium and erythrocytes (Fig. 11).
Hyperplasia of the urothelium lining the
renal pelvis was seen in all groups, but
particularly in saccharin-treated ones, and
usually appeared concurrently with hyper-
plasia of the bladder, i.e. after 85 weeks
(Table III, P<001, Group A; P<0001,
Group B). In untreated rats minimal,
4-5-cell thick hyperplasias mainly in-
volved the renal fornix, occasionally asso-
ciated with sub-epithelial mineralized foci
(Fig. 11). In saccharin-treated animals the
hyperplasias were not only greater than
in controls, but also frequently involved
the epithelium of the renal papilla, often
in conjunction with telangiectasia of
branches of the vasa recta (Fig. 13, Table
II, P<0-001, Group A; P<0-05, Group
B). In this condition the blood vessels
were dilated and congested with thrombi,
some of which became calcified (Fig. 12).
Such vascular changes were uncommon in
control animals. In contrast, the number
ofanimals showing hyalinization ofkidney
tubules and/or glomeruli was marked in
controls and reduced in both saccharin-
treated groups, notably in that receiving
the higher dose of saccharin (P<0001).
A few kidney tumours of diverse histo-
logical appearance were found in treated
and control rats of both sexes (Table II),
including one transitional-cell tumour of
the renal pelvis in a saccharin-treated
female at 85 weeks (Group A). In this
animal, the renal pelvic urothelium was
grossly hyperplastic, of 15-20 cell layers,
and in many places the underlying capil-
laries had proliferated into the epithelium
(Fig. 14). Some areas were papillomatous
or showed early squamous change, whilst
others were characterized by marked
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cellular disorientation, pleomorphism and
a mitotic activity of up to 2 mitoses per
high-power field, Grade 2. The tumour was
diagnosed as a papillary transitional-cell
carcinoma. Although transitional-cell
tumours, either of the bladder, ureter or
kidney, were observed only in saccharin-
treated animals, the combined incidence
of all these tumours in the total "effective
number" of rats given saccharin was not
statistically significant (Table III, P<0.2).
(c) Other organs. Whilst the patho-
logical changes recorded for other major
organs were similar in all groups, there
was a tendency for some organs, particu-
larly the liver and spleen, in rats receiving
saccharin to show a preponderance of
lesions (Table II).
DISCUSSION
To date, the evidence for the carcino-
genicity of saccharin in experimental
animals has appeared equivocal despitethe
variety of methods of administration and
species and strains which have been used
(see Introduction and Schmahl, 1973;
Althoff et al., 1975; Coulston et al., 1975;
Munro et al., 1975; Kroes et al., 1977). We
have studied the effects on rats of high
doses of saccharin given either in drinking
water or in the diet both after life-time
dosing and by examination of representa-
tive animals killed sequentially through-
out the experiment. In particular, such
studies should reveal progressive uro-
thelial changes, such as hyperplasia and/
or dysplasia, which might be expected to
precede tumorigenesis, if saccharin be-
haves like most other urothelial carcino-
gens (Hicks & Chowaniec, 1978).
It is difficult to assess precisely the
effect of saccharin on survival of the rats,
since their mortality curves were some-
what altered by the programme of
scheduled kills plus the unscheduled kills
of sick animals in the second year of the
experiment. However, the survival of all
controls (Group C), particularly males,
was as good as that reported elsewhere for
untreated Wistar rats (e.g. Gaunt et al.,
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1976). Despite the physiological distur-
bances and early deaths in males receiving
saccharin in the drinking water, there was
no significant difference in their mortality
from the controls, possibly because their
marginally reduced diet intake and conse-
quent reduction in growth may have in-
creased their life expectancy (Silberberg &
Silberberg, 1955; Berg, 1967; Ross &
Bras, 1971). There was a tendency for
male rats receiving dietary saccharin to
die before controls and, although not statis-
tically significant, the results are in keeping
with those of Munro et al. (1975), who
observed an increased mortality in males
with chronic dietary levels of saccharin
above 2 g/kg/day. This may reflect a toxic
or metabolic effect ofhigh saccharin levels
to which males are particularly susceptible.
The growth curves and urinary pH
values together demonstrate that more
physiological problems arise from ad-
ministering saccharin in solution than if it
is given, even at double the dose, in the
diet. Thus, although some growth reduc-
tion was seen in all saccharin-treated
animals, it was most marked in males
receiving the sweetener in the drinking
water. In these animals, not only was the
liquid intake reduced, but there was also
voluntary diet restriction; the two pheno-
mena are known to be interdependent
(Cizek&Nocenti, 1965). Ratsreceivingdiet-
ary saccharin also had a depressed growth
rate even though there was no reduction
in either food or water consumption. This
confirms observations from other labora-
tories where saccharin was fed at levels
above2g/kg/day (Munroetal., 1975; Arnold
et al., 1978). The reduced calorific value of
thedietandthetreatment-related increased
water content ofthe faeces may both have
contributed to the lowered weight gain.
Their concomnitant increased fluid con-
sumption, similarly found in other rats fed
high dietary saccharin levels (Munro et al.,
1975; Arnold et al., 1979) may have com-
pensated for the mild diarrhoea, which
suggests accumulation of osmotically
active caecal material (Leegwater et al.,
1974).
The increased urinary alkalinity initially
seen in many males in Group A could
theoretically have resulted from inhibition
of carbonic anhydrase activity in the
kidney by the saccharin contaminant,
OTS, since other sulphonamides show
similar inhibitory properties (Krebs, 1948;
Miller et al., 1950; Levi et al., 1971). Such
a rise in the pH predisposes to urolithiasis
by precipitating inorganic ions in the
urine (Vermeulen et al., 1951) and the
resulting tendency to crystalluria in these
males may have been exacerbated by their
decreased fluid intake. However, no rise in
urinary p1H was seen in any Group B
animals despite their higher OTS intake.
Their increased fluid intake, which can
lead to the production of copious, hypo-
tonic urine (see Arnold et al., 1979)
apparently prevented alkalinization of the
urine. Even so, male animals in this group
showed an increased incidence of mineral-
ization of the bladder and kidneys.
Mineralization of the urinary tract, par-
ticularly in males, is also evident in other
saccharin studies (Lessel, 1971; Taylor &
Friedman, 1974), but it has been observed
that males have a greater tendency than
female rats to form urinary concretions in
other experimental situations (Dunning
et al., 1947; Weil et al., 1965). Moreover,
the anatomy ofthe male bladder neck may
favour stone retention (Casey et al., 1978).
A representative calculus from one of our
saccharin-treated male rats was composed
of magnesium ammonium phosphate, that
is, struvite (infra-red analysis, courtesy of
Dr J. W. Shaw, Boots Co. Ltd, England).
Elevated urinary phosphate, magnesium
and calcium levels have been reported in
male rats fed high dietary levels of
saccharin. These factors may well pre-
dispose to struvite formation but its pre-
cipitation may depend on urinary pH and
volume (Toxicology Forum, 1978).
It is debatable whether the increase in
urothelial hyperplasias found in saccharin-
treated animals was directly attributable
to the sweetener, or was a secondary re-
sponse to the altered physiological state of
the animal. It has been argued that any
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proliferative or carcinogenic effect of
saccharin on the bladder may be attributed
to iatrogenic urolithiasis (Lessel, 1971;
National Research Council, 1974; Toxi-
cology Forum, 1977). In male rats re-
ceiving saccharin in the drinking water,
crystalluria may well have accounted for
the hyperplasia we found before the addi-
tion of ammonium chloride, but uro-
lithiasis was clearly not related to the late-
developing hyperplasias in saccharin-
treated rats, irrespective of how the
sweetener was administered. Nevertheless,
the 3 tumours in the bladders ofsaccharin-
fed male rats were all associated with
mineralization. In other studies also,
bladder tumours occurred preferentially
in male rats fed high levels of saccharin
(Taylor & Friedman, 1974; Tisdel et al.,
1974; Arnold et al., 1979) but there was no
consistent relationship between uro-
lithiasis and bladder tumours. Discrep-
ancies in urolithiasis between different
studies could reflect variation in dietary
cation, carbohydrate or protein content,
all of which may affect urine composition
(Andersen, 1962; Lyon et al., 1966;
Woodard, 1971; Massry & Coburn, 1973).
The urolithiasis associated with our 3
bladder tumours consisted of free-lying
calculi and/or mineralized deposits ad-
herent to or within the tumours. Free-
lying calculi formed in the urine are known
to predispose to bladder tumour forma-
tion (Chapman et al., 1973) but whether
the mineralized deposits that we found,
some ofwhich lie beneath the basal lamina,
also contribute to tumorigenesis is de-
batable. In the latter situation the con-
cretions could be a product of tissue
necrosis which is concomitant with tumour
growth. Distinction between the two types
of calcification might assist interpretation
of the conflicting published observations
relating calcification to bladder tumours.
Without this information it is impossible
at present to assess the relevance of
urolithiasis to urothelial tumour induc-
tion.
There is no consistent relationship
between urothelial hyperplasias in the
kidneys of saccharin-treated animals and
kidney calcification. Although both the
incidences of microcalculi and of renal
pelvic urothelial hyperplasia in saccharin-
treated animals were indeed greater than
in controls, significantly so in the males,
the incidence of intra- or sub-epithelial
mineralization in the renal pelvis, a more
likely source of epithelial irritation, was
similar in treated and control groups.
Furthermore, a urothelial tumour occurred
in the renal pelvis of one female in which
there was no such mineralization.
Of the other kidney lesions reported,
telangiectasia of the vasa recta was a
frequent finding in our saccharin-treated
animals; comparable vascular changes
have been reported in other saccharin-fed
rats (Fitzhugh et al., 1951; Arnold et al.,
1979). Analogous calcifying lesions and
associated renal papillary hyperplasia are
seen in rats fed modified starches, which
are not reported to induce urothelial
tumours (de Groot et al., 1974). Saccharin
is cleared from the kidney by active
tubular secretion (Goldstein et al., 1978)
but this mechanism appears to be satur-
able in animals fed above 5%0 saccharin in
the diet, producing accumulation of
saccharin in the plasma and tissues (Toxi-
cology Forum, 1978). Renal telangiectasis
may thus indicate a pharmacological effect
ofsaccharin, since, in those studieswhereit
has been found, high levels of the sweet-
ener were used. Alternatively, telangi-
ectasis could form part of a neoplastic
response in the kidney, since a similar
condition, concomitant with hyperplasia
ofthe renal papilla, is induced in the rat by
methylnitrosourea (unpublished observa-
tions) and by the suspected renal carcino-
gen phenacetin (Johansson & Angervall,
1976). There was significantly less protein-
uria or hyalinization of the renal tubules
in the saccharin-treated animals than in
control groups. Tubular hyalinization is
commonly observed in ageing rats (Perry,
1965; Berg, 1967). The decreased incidence
of this condition in saccharin-treated rats
of both sexes may be related to their re-
duced body weights relative to controls,
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since reduced obesity can decrease neph-
rosis and tubular protein deposition (Sax-
ton & Kimball, 1941; Simms, 1967).
The first suggestion that saccharin
might beassociated with neoplastic disease
was made by Fitzhugh et al. (1951), who
observed anincreasedincidence oflympho-
sarcomas in rats fed high levels of
saccharin. Lymphoid tumours were more
frequent in the saccharin-fed rats of
Munro et al. (1975) and also in ours, par-
ticularly the males. In addition, extra-
medullary haematopoiesis in the spleen
(SEH) was notable in females fed the
higher dose of saccharin and, since this
can develop before the appearance ofboth
virally-induced lymphomas and spon-
taneous leukaemia in rodents (Boiron et
al., 1965; Siegler & Rich, 1964; Coleman
et al., 1977), SEH could indicate pre-
neoplasia of the reticuloendothelial or
haematopoietic tissues in our animals.
However, the incidence of haematopoietic
or lymphoid tumours in rats may be
affected by other conditions, including
reduced protein intake (Ross & Bras,
1973), increasing age, particularly in
males (Swaen & Van Heerde, 1973) and
oncogenic viruses (Pollard & Kajima,
1966). Whether high doses of saccharin
affect the incidence of lymphoid tumours
in rats by modifying the host response to
such factors, or whether the sweetener has
a more direct action on the reticulo-
endothelial/haematopoietic tissues, it is
impossible to say at present.
Most evidence suggests that saccharin
is hardly metabolized in the rat or monkey
(Pitkin et al., 1971; Kennedy et al., 1972;
Matthews et al., 1973; Lethco & Wallace,
1975) and not at all in man (Byard et al.,
1974; Golberg, 1974). Although we found
elevated incidences of hepatic zonal
necrosis and proliferating periportal bile
ducts in the saccharin-treated rats, neither
saccharin nor the trace amounts of
metabolites which are produced (o-sulph-
amoylbenzoic acid or ammonium o-car-
boxybenzenesulphonate) have been shown
to be toxic in the dog or rat, even at high
doses (Kennedy et al., 1976). Nevertheless,
saccharin is not entirely biologically inert;
it is, for example, the most effective in-
hibitor, among a variety of structural
analogues tested, of phosphotransferase
and phosphohydrolase activities of glu-
cose-6-phosphatase (Lygre, 1974). Fur-
thermore, at concentrations estimated to
be excreted in human urine, it significantly
inhibits guanylate cyclase activity in
various tissues, including the liver and
urinary bladder (Vesely & Levey, 1978).
The evidence that saccharin is a solitary
bladder carcinogen is still equivocal. Un-
doubtedly, an increase in urothelial hyper-
plasia is related to the saccharin treat-
ment; in the mouse, similar slow-growing
urothelial hyperplasia can be preneoplas-
tic (Levi et al., 1971). Saccharin clearly has
some biological activity in rodents; more
bladder tumours are found in rats fed
saccharin than in those which are not, and,
in both this study and others, the tumours
occur predominantly in males after a long,
often 2-year latent period (Lessel, 1971;
Taylor & Friedman, 1974; Tisdel et al.,
1974; Arnold et al., 1979). With the ex-
ception of 2 generation feeding studies
(Taylor & Friedman, 1974; Tisdel et al.,
1974; Arnold et al., 1979) however, in any
single study the tumour incidence is too
low to be statistically significant. Thus,
the experimental evidence for saccharin as
a solitary bladder carcinogen is inevitably
controversial, for much larger numbers of
animals than have been used so far are
required to detect a low tumour incidence
of statistical significance. Much epi-
demiological and experimental evidence
(Peto, 1977) supports the hypothesis that
carcinogenesis is a multifactorial or multi-
stage process, involving initiation, promo-
tion and propagation of tumour growth.
Most powerful solitary carcinogens can
initiate carcinogenesis, their metabolites
can be demonstrated to interact with
DNA and they are mutagenic in a variety
of test systems. By contrast, saccharin
does not appear to react with DNA (Lutz
& Schlatter, 1977) and evidence for its
mutagenicity in a variety of other test
systems is debatable (e.g. Kramers, 1975;
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Batzinger et al., 1977; Stoltz et al., 1977;
Wolff & Rodin, 1978). If the low tumour
incidence in saccharin-treated rodents, in
this laboratory and in others, does reflect
a direct biological effect of the saccharin,
the sweetener is probably acting at a
later stage in the neoplastic process
than initiation.
There is already evidence that saccharin
will promote tumour growth in an experi-
mental system in which neoplasia has been
deliberately initiated by a low dose of a
known carcinogen (Hicks et al., 1978) and
this has recently been confirmed, both in
vivo (Cohen et al., 1978) and in vitro
(Mondal et al., 1978). We have discussed
the possible relevance of saccharin's pro-
moting activity to the human situation
(Hicks & Chowaniec, 1977). Promoters
characteristically produce hyperplasia and
raise the mitotic index; both effects were
seen in the urothelium of our saccharin-
treated rats. Despite standard precau-
tionary measures, laboratory animals may
be exposed to trace amounts of chemical
carcinogens, such as nitrosamine contami-
nants in the diet (e.g. from fishmeal),
endogenously produced carcinogenic
metabolites (e.g. tryptophan derivatives)
or may even carry oncogenic viruses, any
of which might produce the first initiating
event in a multistage sequence of carcino-
genesis. Most of the tumorigenic effects of
saccharin could be accounted for on the
assumption that it is promoting latent, or
dormant, tumour cells already present in
the experimental population. Thus, the
equivocal results obtained with saccharin-
treated rodents may reflect the problems
inherent in attempting to assess the effect
of a single variable in a multifactorial
process.
The results presented in this paper
demonstrate that when saccharin was
administered in the drinking water, con-
siderable physiological disturbances in-
cluding iatrogenic urolithiasis ensued.
Despite this, no bladder tumours occurred
in these animals. As in other studies,
bladder tumours developed only in animals
treated with high doses of saccharin (i.e.
at or above 5 0 of the diet). We have
followed the histogenesis of urothelial
changes by sequential sampling, and have
shown that the low bladder-tumour inci-
dence is superimposed on a background of
urothelial hyperplasias which are signifi-
cantly linked to the saccharin treatment.
If the animals had been kept into their
3rd year, which would have been more
analogous to the 7th and 8th decades in
man, it is possible that sufficient time
would have elapsed to allow any neo-
plastic potential of these slow-growing
hyperplasias to be expressed.
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